| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals, Inc. (CRVS) has 8 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. CRVS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.34M | $99.35M | - | |
| CEO | 1.00M | $11.91M | - | |
| Other | 400.0K | $4.76M | - | |
| CFO | 400.0K | $4.76M | - | |
| Other | 100.0K | $1.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 13, 2016 | Miller Richard A Md64 | President And CEO | Buy | 30,300 | $10.00 | $302,981.01 | +1.4% | |
| May 12, 2016 | Novo A/s58 | 10% Owner | Buy | 70,000 | $10.00 | $700,000.00 | +2.2% | |
| Mar 29, 2016 | Gould Terry P | Director, 10% Owner | Buy | 200,000 | $15.00 | $3,000,000.00 | +8.0% | |
| Mar 29, 2016 | Adams Street Partners LLC | 10% Owner | Buy | 200,000 | $15.00 | $3,000,000.00 | +8.0% | |
| Mar 29, 2016 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 550,000 | $15.00 | $8,250,000.00 | +11.7% | |
| Mar 29, 2016 | Thompson Peter A.65 | Director, 10% Owner | Buy | 550,000 | $15.00 | $8,250,000.00 | +11.7% | |
| Mar 29, 2016 | Novo A/s58 | 10% Owner | Buy | 666,666 | $15.00 | $9,999,990.00 | +26.8% |